MWVC
Morgens Waterfall Vintiadis & Co Portfolio holdings
AUM
$136M
This Quarter Return
+7.35%
1 Year Return
+103.3%
3 Year Return
+567.71%
5 Year Return
+1,003.82%
10 Year Return
+9,424.15%
AUM
$159M
AUM Growth
+$159M
(+13%)
Cap. Flow
+$13.9M
Cap. Flow
% of AUM
8.74%
Top 10 Holdings %
Top 10 Hldgs %
41.49%
Holding
61
New
16
Increased
8
Reduced
5
Closed
17
Top Buys
| 1 |
JPMorgan Chase
JPM
|
$7.79M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
$4.42M |
| 3 |
Goldman Sachs
GS
|
$4.39M |
| 4 |
CAVM
Cavium, Inc.
CAVM
|
$4.34M |
| 5 |
Apple
AAPL
|
$4.14M |
Top Sells
| 1 |
Insulet
PODD
|
$7.2M |
| 2 |
SPDR S&P Retail ETF
XRT
|
$5.05M |
| 3 |
Medtronic
MDT
|
$4.29M |
| 4 |
Delta Air Lines
DAL
|
$4.27M |
| 5 |
American Airlines Group
AAL
|
$3.25M |
Sector Composition
| 1 | Healthcare | 24.73% |
| 2 | Technology | 20.89% |
| 3 | Financials | 15.53% |
| 4 | Communication Services | 10.21% |
| 5 | Consumer Discretionary | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$140B
| $8.99M | 5.66% |
76,800
-18,200
| -19% | -$2.13M |
|
2
Meta Platforms (Facebook)
META
$1.86T
| $7.98M | 5.02% |
93,000
+4,000
| +4% | +$343K |
|
|
3
JPMorgan Chase
JPM
$829B
| $7.79M | 4.9% |
+115,000
| New | +$7.79M |
|
4
Cardiff Oncology
CRDF
$140M
| $7.77M | 4.89% |
765,000
+165,000
| +28% | +$1.67M |
|
|
FCH
5
DELISTED
Felcor Lodging Trust
FCH
| $7.71M | 4.85% |
780,000
+20,000
| +3% | +$198K |
|
|
6
Apple
AAPL
$3.45T
| $5.9M | 3.71% |
47,000
+33,000
| +236% | +$4.14M |
|
7
NXP Semiconductors
NXPI
$59.2B
| $5.89M | 3.71% |
60,000
+1,000
| +2% | +$98.2K |
|
|
AMAG
8
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $4.83M | 3.04% |
70,000
| – | – |
|
9
Mastercard
MA
$538B
| $4.67M | 2.94% |
50,000
| – | – |
|
|
XLNX
10
DELISTED
Xilinx Inc
XLNX
| $4.42M | 2.78% |
+100,000
| New | +$4.42M |
|
|
11
Goldman Sachs
GS
$226B
| $4.39M | 2.76% |
+21,000
| New | +$4.39M |
|
|
CAVM
12
DELISTED
Cavium, Inc.
CAVM
| $4.34M | 2.73% |
+63,000
| New | +$4.34M |
|
|
CELG
13
DELISTED
Celgene Corp
CELG
| $4.05M | 2.55% |
35,000
| – | – |
|
14
Lowe's Companies
LOW
$145B
| $4.02M | 2.53% |
60,000
| – | – |
|
15
Qorvo
QRVO
$8.4B
| $4.01M | 2.53% |
50,000
-8,500
| -15% | -$682K |
|
16
Zimmer Biomet
ZBH
$21B
| $3.93M | 2.47% |
+36,000
| New | +$3.93M |
|
17
Pfizer
PFE
$141B
| $3.86M | 2.43% |
115,000
-50,000
| -30% | -$1.68M |
|
18
ON Semiconductor
ON
$20.3B
| $3.59M | 2.26% |
307,000
+47,000
| +18% | +$549K |
|
19
Toll Brothers
TOL
$13.4B
| $3.34M | 2.1% |
+87,500
| New | +$3.34M |
|
20
IAC Inc
IAC
$2.94B
| $3.27M | 2.05% |
+41,000
| New | +$3.27M |
|
|
ATML
21
DELISTED
ATMEL CORP
ATML
| $3.2M | 2.02% |
+325,000
| New | +$3.2M |
|
|
AGN
22
DELISTED
Allergan plc
AGN
| $3.19M | 2% |
10,500
| – | – |
|
23
Biogen
BIIB
$19.4B
| $3.15M | 1.98% |
+7,800
| New | +$3.15M |
|
24
Citizens Financial Group
CFG
$22.6B
| $3.14M | 1.98% |
+115,000
| New | +$3.14M |
|
25
Skyworks Solutions
SWKS
$11.1B
| $3.12M | 1.97% |
30,000
+13,000
| +76% | +$1.35M |
|